Edition:
United States

Tigenix NV (TIG.OQ)

TIG.OQ on NASDAQ Stock Exchange Global Select Market

41.98USD
25 Jul 2018
Change (% chg)

-- (--)
Prev Close
$41.98
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
--
52-wk High
$47.59
52-wk Low
$37.10

Chart for

About

TiGenix NV is a Belgium-based biopharmaceutical company focused on the development and commercialization of therapeutics from its platforms of allogeneic, or donor-derived, expanded stem cells. The Company's two products from the adipose-derived stem cell platform are in clinical development. Cx601 is in Phase III for the... (more)

Overall

Beta: 0.11
Market Cap(Mil.): €522.99
Shares Outstanding(Mil.): 296.07
Dividend: --
Yield (%): --

Financials

  TIG.OQ Industry Sector
P/E (TTM): -- 88.11 35.99
EPS (TTM): -0.28 -- --
ROI: -105.02 10.12 12.72
ROE: -148.10 10.40 13.73

Earnings vs. Estimates